Exicure reported the appointment of James Sulat to its Board of Directors. James "Jim" Sulat joins Exicure after decades of experience advising and leading biopharmaceutical companies, including serving in the roles of President, Chief Executive Officer and Chief Financial Officer at various companies. Sulat currently serves on the boards of directors of Valneva SE and Arch Therapeutics and previously served on the boards of directors of other companies including Amag Pharmaceuticals, Momenta Pharmaceuticals and Tolero Pharmaceuticals. Exicure also announced that Jay Venkatesan has stepped down from the Board of Directors, as of December 29, 2020.